Welcome to LookChem.com Sign In|Join Free
  • or
BOC-S-TERT-BUTYLMERCAPTO-L-CYSTEINE is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

30044-61-2

Post Buying Request

30044-61-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

30044-61-2 Usage

Chemical Properties

White to off-white powder

Check Digit Verification of cas no

The CAS Registry Mumber 30044-61-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,0,0,4 and 4 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 30044-61:
(7*3)+(6*0)+(5*0)+(4*4)+(3*4)+(2*6)+(1*1)=62
62 % 10 = 2
So 30044-61-2 is a valid CAS Registry Number.
InChI:InChI=1/C12H23NO4S2/c1-11(2,3)17-10(16)13-8(9(14)15)7-18-19-12(4,5)6/h8H,7H2,1-6H3,(H,13,16)(H,14,15)

30044-61-2 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (15375)  Boc-Cys(StBu)-OH  ≥99.0% (TLC)

  • 30044-61-2

  • 15375-5G

  • 2,149.29CNY

  • Detail

30044-61-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name BOC-S-TERT-BUTYLMERCAPTO-L-CYSTEINE

1.2 Other means of identification

Product number -
Other names N-(tert-butoxycarbonyl)-S-tert-butylmercapto-L-cysteine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:30044-61-2 SDS

30044-61-2Relevant academic research and scientific papers

PHOTOLYTIC COMPOUNDS AND TRIPLET-TRIPLET ANNIHILATION MEDIATED PHOTOLYSIS

-

Paragraph 0026; 00203, (2021/04/17)

The invention provides novel photolytic compounds and prodrugs, nanoparticles and compositions thereof, and methods of conducting photolysis mediated by triplet-triplet annihilation.

Total synthesis of the cyclic depsipeptide YM-280193, a platelet aggregation inhibitor

Kaur, Harveen,Harris, Paul W. R.,Little, Peter J.,Brimble, Margaret A.

supporting information, p. 492 - 495 (2015/03/05)

The first total synthesis of YM-280193, a cyclic depsipeptide that inhibits the ADP-induced aggregation of human platelets, is described. The monomer and dipeptide fragments were prepared using conventional chemistry and subsequently assembled by Fmoc-solid-phase peptide synthesis (Fmoc-SPPS). A late-stage novel bis-alkylation-elimination of cysteine on-resin was employed to introduce the unnatural N-methyldehydroalanine moiety. The final step involved execution of a key macrolactamization reaction between the hindered unnatural N,O-dimethylthreonine and ?2-hydroxyleucine residues.

A comprehensive one-pot synthesis of protected cysteine and selenocysteine SPPS derivatives

Flemer, Stevenson

, p. 1257 - 1264 (2015/04/14)

A proof-of-principle methodology is presented in which all commercially-available cysteine (Cys) and selenocysteine (Sec) solid phase peptide synthesis (SPPS) derivatives are synthesized in high yield from easily prepared protected dichalcogenide precursors. A Zn-mediated biphasic reduction process applied to a series of four bis-Nα-protected dichalcogenide compounds allows facile conversion to their corresponding thiol and selenol intermediates followed by insitu S- or Se-alkylation with various electrophiles to directly access twenty one known Cys and Sec SPPS derivatives. Most of these derivatives were able to be precipitated in crude form out of petroleum ether in sufficient purity for direct use as peptide building blocks. Subsequent incorporation of these derivatives into peptide models nicely illustrates their viability and applicability toward SPPS.

Towards nucleopeptides containing any trifunctional amino acid (II)

Debéthune, Laurent,Marchán, Vicente,Fàbregas, Gemma,Pedroso, Enrique,Grandas, Anna

, p. 6965 - 6978 (2007/10/03)

Nucleopeptides with no restriction in the amino acid composition can be synthesized using stepwise solid-phase methodology. Best conditions for the protection of arginine and cysteine, as well as for the final deprotection treatment are established, and o

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 30044-61-2